NCT06567197View on ClinicalTrials.gov

Multiple Sclerosis Treatment With Autologous Hematopoietic Stem Cell Transplantation in the Netherlands

RecruitingOBSERVATIONAL

Enrollment

24

Participants

Timeline

Start Date

August 25, 2023

Primary Completion Date

September 1, 2028

Study Completion Date

September 1, 2028

Conditions

Multiple Sclerosis, Relapsing-Remitting

Trial Locations (2)

Unknown

RECRUITING

Amsterdam UMC, Amsterdam

RECRUITING

St. Antonius Hospital, Nieuwegein

All Listed Sponsors

collaborator

St. Antonius Hospital

OTHER

lead

Amsterdam UMC, location VUmc

OTHER